Literature DB >> 2175461

Calcium antagonists. History and perspective.

D J Triggle1.   

Abstract

The calcium channel antagonists are a heterogeneous group of drugs acting on one class of voltage-dependent channel. Their modes and sites of actions are reviewed in this historical perspective and placed in the context of the cellular events underlying homeostasis. Calcium channel antagonists should be regarded as a subset of a larger family of Ca2+ modulators, agents that block or activate functions at a variety of control loci for Ca2+ homeostasis. In a number of important respects, the Ca2+ channel may be viewed as a pharmacologic receptor that defines the existence of specific drug binding sites and their regulation by homologous and heterologous influences. We describe the factors that define the selectivity of action of channel antagonists, with particular emphasis on state-dependent interactions controlled by voltage-modulated drug interactions, and discuss future developments in Ca2+ channel ligands, emphasizing the contributions of molecular biology and the development of more specific and selective agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175461

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

Review 1.  Phenotypic screens as a renewed approach for drug discovery.

Authors:  Wei Zheng; Natasha Thorne; John C McKew
Journal:  Drug Discov Today       Date:  2013-07-09       Impact factor: 7.851

Review 2.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 3.  1,4-Dihydropyridines as calcium channel ligands and privileged structures.

Authors:  David J Triggle
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.